Sarepta Therapeutics Inc (LTS:0L35)
$ 121.67 0 (0%) Market Cap: 11.61 Bil Enterprise Value: 11.80 Bil PE Ratio: 78.90 PB Ratio: 9.50 GF Score: 82/100

Q4 2019 Sarepta Therapeutics Inc Earnings Call Transcript

Feb 26, 2020 / 09:30PM GMT
Release Date Price: $123.86
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Sarepta Therapeutics Fourth Quarter 2019 Earnings Call. (Operator Instructions) As a reminder, today's program may be recorded.

I would now like to introduce your host for today's program, Ian Estepan, Senior Vice President, Chief of Staff and Corporate Affairs. Please go ahead, sir.

Ian M. Estepan
Sarepta Therapeutics, Inc. - Senior VP of Corporate Affairs & Chief of Staff

Thank you so much, John, and thank you all for joining today's call. Earlier today, we released our financial results for the fourth quarter and full year 2019. The press release is available on our website at www.sarepta.com, and our 10-K was filed with the SEC earlier this afternoon. Joining us on the call today are Doug Ingram, Sandy Mahatme, Bo Cumbo, Dr. Gilmore O'Neill and Dr. Louise Rodino-Klapac. After our formal remarks, we'll open up the call for Q&A.

I'd like to note that during this call, we will be making a number of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot